<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03810859</url>
  </required_header>
  <id_info>
    <org_study_id>K180404J</org_study_id>
    <secondary_id>2018-A01250-55</secondary_id>
    <nct_id>NCT03810859</nct_id>
  </id_info>
  <brief_title>Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants</brief_title>
  <acronym>EXODENT</acronym>
  <official_title>Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OSCAR</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation Maladie Rare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ExoDent specifically aims to discover new genes and new mutations causing isolated
      amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) and other dentin anomalies.
      The key point for clinicians is to distinguish between non syndromic and syndromic disorders
      in order to improve patients guidance and counseling. To do so, two targeted NGS panel have
      been designed, one searching for isolated AI and the other for DI. After 18 months, some
      families remain without any positive results. ExoDent project proposes those negative
      patients a Whole Exome Sequencing (WES) approach to deeper explore their genetic background.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2019</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Genome sequencing</measure>
    <time_frame>After one day</time_frame>
    <description>Pathogenic variants identification and qualification</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Amelogenesis Imperfecta</condition>
  <condition>Dentinogenesis Imperfecta</condition>
  <condition>Dentin Anomalies</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Adults : 7 to 10 mL Childs : 2 to 4 mL</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of amelogenesis imperfecta or dentinogenesis imerfecta or other
             dentin anomaly with no other signs or symptoms ( familial or isolated)

          -  negative results after targeted NGS strategy for molecular diagnosis

        Exclusion Criteria:

          -  absence of positive clinical diagnosis

          -  Diagnosis of syndromic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline GAUCHER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline GAUCHER, MD</last_name>
    <phone>(33)1 58 41 12 17</phone>
    <email>celine.gaucher@parisdescartes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline TOURTE</last_name>
    <phone>(33)1 58 41 11 90</phone>
    <email>caroline.tourte@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline GAUCHER, MD</last_name>
      <phone>(33)1 58 4112 17</phone>
      <email>celine.gaucher@parisdescartes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 17, 2019</study_first_submitted>
  <study_first_submitted_qc>January 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2019</study_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amelogenesis imperfecta</keyword>
  <keyword>Dentinogenesis imperfecta</keyword>
  <keyword>Dentin anomalies</keyword>
  <keyword>Whole Exome Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amelogenesis Imperfecta</mesh_term>
    <mesh_term>Dentinogenesis Imperfecta</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

